Inventor · disambiguated record
Paul J. Gilligan
Also filed as: GILLIGAN PAUL · GILLIGAN PAUL J · GILLIGAN PAUL JOSEPH
58 granted patents·7 pending applications·1,333 citations·filing 1984–2017
99Inventor score
Files withBRISTOL MYERS SQUIBB CO16BRISTOL MYERS SQUIBB PHARMA CO14DU PONT PHARM CO14DU PONT MERCK PHARMA7PFIZER3
Top patents by PatentIndex Score
65 records- 0197US6191131B1Azolo triazines and pyrimidinesDU PONT PHARM CO·Filed 1998·Granted Feb 20, 2001·107 cites·35 claims
- 0297US6107301A1N-alkyl-N-arylpyrimidinamines and derivatives thereofDU PONT PHARM CO·Filed 1997·Granted Aug 22, 2000·192 cites·9 claims
- 0396US6342503B11N-alkyl-n-arylpyrimidinamines and derivatives thereofDU PONT PHARM CO·Filed 1998·Granted Jan 29, 2002·144 cites·7 claims
- 0496US6060478AAzolo triazines and pyrimidinesDU PONT PHARM CO·Filed 1998·Granted May 9, 2000·117 cites·28 claims
- 0595US8367709B2Dipeptide analogs as coagulation factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Feb 5, 2013·42 cites·11 claims
- 0694US4623650AAntibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acidsPFIZER·Filed 1984·Granted Nov 18, 1986·43 cites·17 claims
- 0793US6448261B1Arylamino fused pyridinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Sep 10, 2002·55 cites·9 claims
- 0892US9902742B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 27, 2018·5 cites·13 claims
- 0992US9611274B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 4, 2017·5 cites·14 claims
- 1092US6124289AAzolo triazines and pyrimidinesDU PONT PHARM CO·Filed 1997·Granted Sep 26, 2000·57 cites·21 claims
- 1191US9221818B2Macrocycles as factor XIa inhibitorsPINTO DONALD J P·Filed 2012·Granted Dec 29, 2015·13 cites·11 claims
- 1291US7626039B2Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 1, 2009·14 cites·14 claims
- 1391US7144894B2Sulfonamide bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 5, 2006·9 cites·16 claims
- 1491US6358950B1Azolo triazines and pyrimidinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 19, 2002·23 cites·8 claims
- 1591US5532243AAntipsychotic nitrogen-containing bicyclic compoundsDU PONT MERCK PHARMA·Filed 1992·Granted Jul 2, 1996·47 cites·48 claims
- 1689US6589952B2Imidazo[1,2-a]pyrazines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jul 8, 2003·30 cites·22 claims
- 1789US6258809B16-aryloxy and arylthiopurinesDU PONT PHARM CO·Filed 2000·Granted Jul 10, 2001·21 cites·5 claims
- 1889US5169855APiperidine ether derivatives as psychotropic drugs or plant fungicidesDU PONT MERCK PHARMA·Filed 1990·Granted Dec 8, 1992·41 cites·21 claims
- 1986US7678793B2Azolo triazines and pyrimidinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Mar 16, 2010·3 cites·4 claims
- 2086US6579876B2Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Jun 17, 2003·12 cites·6 claims
- 2186US6525056B2Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disordersBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 25, 2003·22 cites·16 claims
- 2286US4636506A7-heterocyclic-1,4-dihydroquinolonesPFIZER·Filed 1985·Granted Jan 13, 1987·25 cites·12 claims
- 2384US7358252B24-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligandsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Apr 15, 2008·4 cites·2 claims
- 2483US7842708B2Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Nov 30, 2010·4 cites·16 claims
- 2582US7662817B24-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligandsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2008·Granted Feb 16, 2010·3 cites·6 claims
- 2680US7319100B2Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligandsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Jan 15, 2008·3 cites·7 claims
- 2779US6518271B11H-imidazo[4,5-d]pyridazin-7-one, and corresponding thiones as corticotropin releasing factor (CRF) receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Feb 11, 2003·11 cites·13 claims
- 2879US6136809AAzolo triazines and pyrimidinesDU PONT PHARM CO·Filed 1998·Granted Oct 24, 2000·18 cites·4 claims
- 2978US6521636B1Imidazo-pyridines as corticotropin releasing factor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Feb 18, 2003·6 cites·3 claims
- 3077US7157578B24-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligandsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jan 2, 2007·6 cites·3 claims
- 3177US6313124B1Tetrazine bicyclic compoundsDU PONT PHARM CO·Filed 1998·Granted Nov 6, 2001·53 cites·14 claims
- 3277US6174912B1Nitrogen substituted imidazo[4,5-C]pyrazoles as corticotropin releasing hormone antagonistsDU PONT PHARM CO·Filed 1998·Granted Jan 16, 2001·21 cites·11 claims
- 3376US6107300AArylamino fused pyrimidinesDU PONT PHARM CO·Filed 1997·Granted Aug 22, 2000·35 cites·9 claims
- 3475US6958341B2Pyrazolopyrimidines as CRF antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Oct 25, 2005·8 cites·11 claims
- 3574US9409908B2Dihydropyridone p1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 9, 2016·1 cites·14 claims
- 3674US6124300AAryloxy- and arylthio- fused pyridines and pyrimidines and derivativesDU PONT PHARM CO·Filed 1997·Granted Sep 26, 2000·32 cites·15 claims
- 3773US4797490AProcess for the preparation of 3-(2'-fluorophenyl)pyridinePFIZER·Filed 1986·Granted Jan 10, 1989·11 cites·8 claims
- 3870US6245769B1Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disordersDU PONT PHARM CO·Filed 1998·Granted Jun 12, 2001·25 cites·15 claims
- 3966US7205306B2Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligandsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Apr 17, 2007·2 cites·16 claims
- 4064US8901115B2Cyclic P1 linkers as factor XIa inhibitorsLAM PATRICK Y S·Filed 2012·Granted Dec 2, 2014·1 cites·12 claims
- 4164US6271380B11H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligandsDU PONT PHARM CO·Filed 1999·Granted Aug 7, 2001·18 cites·12 claims
- 4261US10567887B2Plasma speakerGILLIGAN PAUL·Filed 2017·Granted Feb 18, 2020·1 cites·25 claims
- 4361US7094782B1Azolo triazines and pyrimidinesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 22, 2006·1 cites·1 claims
- 4461US5296479ATreatment of psychosis using 1-cycloalkylpiperidinesDU PONT MERCK PHARMA·Filed 1992·Granted Mar 22, 1994·6 cites·25 claims
- 4561US5109002AAntipsychotic 1-cycloalkylpiperidinesDU PONT MERCK PHARMA·Filed 1990·Granted Apr 28, 1992·13 cites·30 claims
- 4659US5116846AN-aralkyl piperidine derivatives as psychotropic drugsDU PONT MERCK PHARMA·Filed 1990·Granted May 26, 1992·6 cites·6 claims
- 4758US8604056B2Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitorsPINTO DONALD J P·Filed 2012·Granted Dec 10, 2013·0 cites·5 claims
- 4858US6103737AAryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonistsDU PONT PHARM CO·Filed 1998·Granted Aug 15, 2000·15 cites·7 claims
- 4956US9108981B2Cyclic P1 linkers as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 18, 2015·0 cites·11 claims
- 5054US9951071B2Dihydropyridone P1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 24, 2018·0 cites·7 claims
Showing the top 50 of 65 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →